Table I.
Characteristics of ten patients with biliary tract cancer that received surgery.
| Characteristics | N |
|---|---|
| Age, median (range) in years | 68 (44–74) |
| Sex | |
| Male | 4 |
| Female | 6 |
| Cancer type | |
| Gallbladder carcinoma | 4 |
| Cholangiocarcinomas | 6 |
| Incidence site | |
| Gallbladder | 4 |
| Intrahepatic bile duct | 1 |
| Hilar bile duct | 4 |
| Distal bile duct | 1 |
| AJCC stage | |
| I | 0 |
| II | 4 |
| III | 3 |
| IV | 3 |
| Operation type | |
| R0 | 8 |
| R1 | 1 |
| R2 | 1 |
| Gallbladder stones | |
| Yes | 4 |
| No | 6 |
| Cholecystitis | |
| Yes | 4 |
| No | 6 |
| Method of obtaining bile | |
| PTCD | 5 |
| Operation | 5 |
| Location of obtaining bile | |
| Gallbladder | 4 |
| Intrahepatic bile duct | 1 |
| Hilar bile duct | 4 |
| Distal bile duct | 1 |
| AFP, median (range) ng/ml | 3.4 (2.4–8.0) |
| CEA, median (range) ng/ml | 4.5 (1.3–83.9) |
| CA19-9, median (range) U/ml | 154.6 (8.8–1,000.0) |
| Total bilirubin, median (range) µmol/l | 42.2 (8.8–305.6) |
AFP, α-fetoprotein; CEA, carcinoembryonic antigen; CA 19-9, carbohydrate antigen 19-9; PTCD, percutaneous transhepatic cholangial drainage.